Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | UNG | P13051 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | FBP1 | P09467 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29569326 | 1.00 | ALDH1A1 (0.48) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL10633500 | 0.82 | FFAR1 (0.58) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL29144796 | 0.80 | CDK4 (0.55) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL29144797 | 0.80 | CDK4 (0.55) | ALDH1A1CA12CA1CA2CA9 | |
| Phenylacetylene SCHEMBL6530256 | 0.80 | ALDH1A1 (0.64) | ALDH1A1FFAR1UNGCYP2A6 | |
| SCHEMBL3109157 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL23158521 | 0.78 | CA12 (0.41) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL2497552 | 0.78 | TDP1 (0.48) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL16953580 | 0.78 | CA12 (0.41) | CA12CA1CA2CA9CA14 | |
| SCHEMBL67236 | 0.78 | FBP1 (0.56) | ALDH1A1FFAR1UNGMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326787-A1 | MANUFACTURING OPTIMIZATION OF GL-2045, A MULTIMERIZING STRADOMER | GLIKNIK INC (US) | 2025-10-23 | — | — | US | claimed |
| CN-119318887-A | Graphite alkyne multilayer composite membrane and preparation method thereof | 北京化工大学 | 2025-01-17 | — | — | CN | claimed |
| CN-115869785-B | Ultrafast preparation method of graphite alkyne composite membrane | 北京化工大学 | 2024-11-26 | — | — | CN | claimed |
| CN-115869785-A | Ultrafast preparation method of graphite alkyne composite membrane | 北京化工大学 | 2023-03-31 | — | — | CN | claimed |
| CN-114437350-B | Polyimide resin and preparation method and application thereof | 波米科技有限公司 | 2022-09-16 | — | — | CN | claimed |
| CN-114437350-A | Polyimide resin and preparation method and application thereof | 波米科技有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-114315686-A | Alkynyl-containing diamine, preparation method thereof and application thereof in preparation of photosensitive resin composition | 波米科技有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-0411549-A1 | 1,4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same | Kaken Pharmaceutical Co., Ltd. (JP) | 1991-02-06 | — | — | EP | claimed |
| EP-0050428-A1 | Ethynylated aromatic compounds and process for making same | Hughes Aircraft Company (US) | 1982-04-28 | — | — | EP | claimed |
| JP-63256623-A | — | — | None | — | — | JP | disclosed |
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | CLEARSIDE BIOMEDICAL, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12624044-B2 | SMARCA degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| US-12572075-B2 | Composition, method of forming resist underlayer film, and method of forming resist pattern | JSR CORPORATION (JP) | 2026-03-10 | — | — | US | disclosed |
| JP-S63256623-A | DIHYDROPYRIDINE RING-CONTAINING POLYMER AND ITS PRODUCTION AND USE | HITACHI LTD | 1988-10-24 | — | — | JP | disclosed |
| US-4766251-A | Process for the preparation of ethynylbenzaldehydes | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1988-08-23 | — | — | US | disclosed |
| US-4730032-A | MOLDING MATERIALS | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1988-03-08 | — | — | US | disclosed |
| EP-0257309-A2 | Process for the preparation of ethynylbenzaldehydes | National Starch and Chemical Investment Holding Corporation (US) | 1988-03-02 | — | — | EP | disclosed |
| US-4465833-A | ALKYNYLATION HALOGENATED BENZENE COMPOUND IN PRESENCE OF METAL CATALYST | HUGHES AIRCRAFT COMPANY (US) | 1984-08-14 | — | — | US | disclosed |
| EP-0050428-A1 | Ethynylated aromatic compounds and process for making same | Hughes Aircraft Company (US) | 1982-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144674-A1 | Apparatus and Methods for Drug Delivery Using Microneedles | PROKR2, SLC10A2, GLP1R | ALDH1A1 4190/4885CA12 1763/4885CA1 3424/4885 |
| US-12572075-B2 | Composition, method of forming resist underlayer film, and method of forming resist pattern | TOP1, NAF1, ASH2L | ALDH1A1 2358/4885CA12 2060/4885CA1 1324/4885 |
| US-12624044-B2 | SMARCA degraders and uses thereof | SMARCA1, SMARCC1, SMARCA2 | ALDH1A1 3543/4885CA12 3603/4885CA1 2045/4885 |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | HTR2C, CNR2, HTR3B | ALDH1A1 2693/4885CA12 2579/4885CA1 2642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.